» Articles » PMID: 24511094

Endogenous Retroviruses and the Development of Cancer

Overview
Journal J Immunol
Date 2014 Feb 11
PMID 24511094
Citations 100
Authors
Affiliations
Soon will be listed here.
Abstract

Mammalian genomes include a considerable number of endogenous retroviruses (ERVs), relics of ancestral infectious retroviruses, whose proviruses have invaded the germ-line. The documented ability of infectious retroviruses to cause cancer has greatly contributed to the discovery of ERVs. It also reinforced the concept that ERVs are causative agents of many cancers, a notion that historically has not always stood up to experimental scrutiny. The recent greater appreciation of the complexity of ERV biology and the identification of dedicated host mechanisms controlling ERV activity have revealed novel interactions between ERVs and their hosts, with the potential to cause or contribute to disease. In this review, the involvement of ERVs in cancer initiation and progression is discussed, as well as their contribution to our understanding of the process of transformation and to the invention of innovative preventive and therapeutic cancer treatments.

Citing Articles

Targeted Variant Assessments of Human Endogenous Retroviral Regions in Whole Genome Sequencing Data Reveal Retroviral Variants Associated with Papillary Thyroid Cancer.

Stricker E, Peckham-Gregory E, Lai S, Sandulache V, Scheurer M Microorganisms. 2025; 12(12.

PMID: 39770638 PMC: 11679660. DOI: 10.3390/microorganisms12122435.


Endogenous viral elements: insights into data availability and accessibility.

Ritsch M, Brait N, Harvey E, Marz M, Lequime S Virus Evol. 2024; 10(1):veae099.

PMID: 39659497 PMC: 11631435. DOI: 10.1093/ve/veae099.


: A HERV Turn-On for Autoimmunity, Neurodegeneration, and Cancer?.

Dow C, Pierce E, Sechi L Microorganisms. 2024; 12(9).

PMID: 39338563 PMC: 11434025. DOI: 10.3390/microorganisms12091890.


Transcriptome analysis of the effect of HERV-K env gene knockout in ovarian cancer cell lines.

Ko E, Suh D, Kim H, Lee J, Eo W, Kim H Genes Genomics. 2024; 46(11):1293-1301.

PMID: 39271536 DOI: 10.1007/s13258-024-01544-4.


Epigenetics and immunotherapy in colorectal cancer: progress and promise.

Dang T, Guan X, Cui L, Ruan Y, Chen Z, Zou H Clin Epigenetics. 2024; 16(1):123.

PMID: 39252116 PMC: 11385519. DOI: 10.1186/s13148-024-01740-9.


References
1.
Blomberg J, Benachenhou F, Blikstad V, Sperber G, Mayer J . Classification and nomenclature of endogenous retroviral sequences (ERVs): problems and recommendations. Gene. 2009; 448(2):115-23. DOI: 10.1016/j.gene.2009.06.007. View

2.
Kalter S, Helmke R, HEBERLING R, PANIGEL M, Fowler A, Strickland J . Brief communication: C-type particles in normal human placentas. J Natl Cancer Inst. 1973; 50(4):1081-4. DOI: 10.1093/jnci/50.4.1081. View

3.
Oricchio E, Sciamanna I, Beraldi R, Tolstonog G, Schumann G, Spadafora C . Distinct roles for LINE-1 and HERV-K retroelements in cell proliferation, differentiation and tumor progression. Oncogene. 2007; 26(29):4226-33. DOI: 10.1038/sj.onc.1210214. View

4.
Dewannieux M, Heidmann T . Endogenous retroviruses: acquisition, amplification and taming of genome invaders. Curr Opin Virol. 2013; 3(6):646-56. DOI: 10.1016/j.coviro.2013.08.005. View

5.
Fan H, Johnson C . Insertional oncogenesis by non-acute retroviruses: implications for gene therapy. Viruses. 2011; 3(4):398-422. PMC: 3186009. DOI: 10.3390/v3040398. View